{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:32:39Z","timestamp":1790865159215,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T00:00:00Z","timestamp":1686182400000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019779","name":"Qatar National Library","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019779","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.heliyon.2023.e17149","type":"journal-article","created":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T19:11:49Z","timestamp":1687374709000},"page":"e17149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Long COVID treated successfully with antivirals in a rituximab-treated follicular lymphoma patient with persistent negative-antibodies to SARS-CoV2"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9343-3400","authenticated-orcid":false,"given":"Elias","family":"Tayar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Isber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidal","family":"Isber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2023.e17149_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105924","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges","volume":"55","author":"Lai","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.heliyon.2023.e17149_bib2","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41586-021-03553-9","article-title":"High-dimensional characterization of post-acute sequelae of COVID-19","volume":"594","author":"Al-Aly","year":"2021","journal-title":"Nat"},{"key":"10.1016\/j.heliyon.2023.e17149_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101019","article-title":"Characterizing long COVID in an international cohort: 7 months of symptoms and their impact","volume":"38","author":"Davis","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.heliyon.2023.e17149_bib4","unstructured":"New data shows long Covid is keeping as many as 4 million people out of work, (n.d.). https:\/\/www.brookings.edu\/research\/new-data-shows-long-covid-is-keeping-as-many-as-4-million-people-out-of-work\/(accessed September 16, 2022)."},{"key":"10.1016\/j.heliyon.2023.e17149_bib5","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1016\/j.cell.2022.06.008","article-title":"Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation","volume":"185","author":"Fern\u00e1ndez-Casta\u00f1eda","year":"2022","journal-title":"Cell"},{"issue":"28","key":"10.1016\/j.heliyon.2023.e17149_bib6","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/s41591-022-01810-6","article-title":"Unexplained post-acute infection syndromes","volume":"285","author":"Choutka","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.heliyon.2023.e17149_bib7","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41586-021-03207-w","article-title":"Evolution of antibody immunity to SARS-CoV-2","volume":"591","author":"Gaebler","year":"2021","journal-title":"Nat"},{"key":"10.1016\/j.heliyon.2023.e17149_bib8","series-title":"SARS-CoV-2 Infection and Persistence throughout the Human Body and Brain","author":"D","year":"2021"},{"key":"10.1016\/j.heliyon.2023.e17149_bib9","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/gutjnl-2021-324280","article-title":"Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19","volume":"71","author":"Cheung","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.heliyon.2023.e17149_bib10","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1097\/PG9.0000000000000152","article-title":"Persistent SARS-CoV-2 Nucleocapsid protein presence in the intestinal epithelium of a pediatric patient 3 Months after acute infection","volume":"3","author":"Arostegui","year":"2022","journal-title":"JPGN Reports"},{"key":"10.1016\/j.heliyon.2023.e17149_bib11","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.cell.2022.01.014","article-title":"Multiple early factors anticipate post-acute COVID-19 sequelae","volume":"185","author":"Su","year":"2022","journal-title":"Cell"},{"issue":"23","key":"10.1016\/j.heliyon.2023.e17149_bib12","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41590-021-01104-y","article-title":"Pathological sequelae of long-haul COVID","volume":"232","author":"Mehandru","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.heliyon.2023.e17149_bib13","unstructured":"COVID Drug May Also Ease Symptoms of Long COVID | UC San Francisco, (n.d.). https:\/\/www.ucsf.edu\/news\/2022\/05\/422771\/covid-drug-may-also-ease-symptoms-long-covid (accessed November 21, 2022)."},{"key":"10.1016\/j.heliyon.2023.e17149_bib14","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41586-021-03553-9","article-title":"High-dimensional characterization of post-acute sequelae of COVID-19","volume":"594","author":"Al-Aly","year":"2021","journal-title":"Nat"},{"key":"10.1016\/j.heliyon.2023.e17149_bib15","unstructured":"Long COVID or Post-COVID Conditions | CDC, (n.d.). https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/long-term-effects\/index.html (accessed September 17, 2022)."},{"key":"10.1016\/j.heliyon.2023.e17149_bib16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejim.2021.06.009","article-title":"Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: a systematic review and meta-analysis","volume":"92","author":"Fern\u00e1ndez-de-las-Pe\u00f1as","year":"2021","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.heliyon.2023.e17149_bib17","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/d41586-022-02140-w","article-title":"Long-COVID treatments: why the world is still waiting","volume":"608","author":"Ledford","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2023.e17149_bib18","doi-asserted-by":"crossref","first-page":"e737","DOI":"10.1016\/S2352-3026(20)30251-9","article-title":"Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study","volume":"7","author":"Passamonti","year":"2020","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.heliyon.2023.e17149_bib19","doi-asserted-by":"crossref","first-page":"312","DOI":"10.5501\/wjv.v10.i6.312","article-title":"COVID-19 (SARS-CoV-2 infection) in lymphoma patients: a review","volume":"10","author":"Bonuomo","year":"2021","journal-title":"World J. Virol."},{"key":"10.1016\/j.heliyon.2023.e17149_bib20","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.3324\/haematol.2013.091025","article-title":"European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia","volume":"98","author":"Averbuch","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.heliyon.2023.e17149_bib21","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S1470-2045(11)70235-2","article-title":"CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group","volume":"12","author":"Pfreundschuh","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.heliyon.2023.e17149_bib22","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.ccell.2021.07.012","article-title":"Antibody response to SARS-CoV-2 vaccines in patients with hematologic malignancies","volume":"39","author":"Greenberger","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.heliyon.2023.e17149_bib23","unstructured":"Prior treatment with cancer drug likely renders COVID-19 vaccine ineffective, study finds | News Center | Stanford Medicine, (n.d.). https:\/\/med.stanford.edu\/news\/all-news\/2022\/02\/rituximab-treatment-covid-19-mrna-vaccines.html (accessed September 17, 2022)."},{"key":"10.1016\/j.heliyon.2023.e17149_bib24","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1158\/2643-3230.BCD-21-0222","article-title":"CD20-Targeted therapy ablates de novo antibody response to vaccination but spares preestablished immunity","volume":"3","author":"Shree","year":"2022","journal-title":"Blood Cancer Discov."},{"issue":"28","key":"10.1016\/j.heliyon.2023.e17149_bib25","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41591-022-01689-3","article-title":"Long-term cardiovascular outcomes of COVID-19","volume":"283","author":"Xie","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.heliyon.2023.e17149_bib26","first-page":"516","article-title":"Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid","volume":"54","author":"Wen","year":"2022","journal-title":") for COVID-19\uff1aMeta-Anal."},{"key":"10.1016\/j.heliyon.2023.e17149_bib27","first-page":"95","article-title":"Effect of oral Nirmatrelvir on long COVID symptoms: 4 cases and rationale for systematic studies","volume":"7","author":"Peluso","year":"2022","journal-title":"Pathog. Immun."},{"key":"10.1016\/j.heliyon.2023.e17149_bib28","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1056\/NEJMoa2116620","article-title":"Intramuscular AZD7442 (Tixagevimab\u2013Cilgavimab) for prevention of covid-19","volume":"386","author":"Levin","year":"2022","journal-title":"N. Engl. J. Med."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023043578?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023043578?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:36:39Z","timestamp":1790469399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023043578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S2405844023043578"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e17149","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long COVID treated successfully with antivirals in a rituximab-treated follicular lymphoma patient with persistent negative-antibodies to SARS-CoV2","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e17149","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e17149"}}